
    
      Single centre, randomised, double-blind, comparator study to demonstrate superiority of
      salmeterol/fluticasone propionate combination product 50/100mcg bd over fluticasone
      propionate 100mcg bd with respect to improvements in airway physiology (sRAW) in adults with
      persistent asthma treated for 4 weeks.
    
  